Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

Ramdev's Patanjali Fails FSSAI Tests, Fined

Patanjali was found guilty of misbranding its products, which were shown as produced at its own units but were in fact manufactured elsewhere.
Patanjali was found guilty of misbranding its products, which were shown as produced at its own units but were in fact manufactured elsewhere.
ramdev s patanjali fails fssai tests  fined
File photo of Acharya Balkrishna and Baba Ramdev of Patanjali Ayurveda. Credit: PTI
Advertisement

Patanjali was found guilty of misbranding its products, which were shown as produced at its own units but were in fact manufactured elsewhere.

File photo of Acharya Balkrishna and Baba Ramdev  of Patanjali Ayurveda. Credit: PTI

File photo of Acharya Balkrishna and Baba Ramdev of Patanjali Ayurveda. Credit: PTI

Dehradun: A local court in Haridwar has slapped the five production units of Baba Ramdev's Patanjali Ayurved with a fine of Rs 11 lakh for "misbranding and putting up misleading advertisements" of their products.

ADM Lalit Narayan Mishra's court has asked the company to pay the fine within a month.

Patanjali Ayurved was found guilty of misbranding as the products being shown by the company as produced at its own units were in fact manufactured somewhere else, the court said.

A case had been filed in the court against the company in 2012 by the District Food Safety Department after samples of mustard oil, salt, pineapple jam, besan and honey produced by Patanjali had failed quality tests at Rudrapur laboratory.

Advertisement

The products were found to be in violation of sections 52-53 of food security norms and section 23.1 (5) of food safety and standard (packaging and labelling) regulation.

Advertisement
This article went live on December fifteenth, two thousand sixteen, at twenty-eight minutes past eleven in the morning.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia